Resources
- sort by:
- Relevance
- Date
- Popularity
- Ogilvy & Mather's Shelly Lazarus Elected to Merck Board of Directors
- WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today announced that Shelly Lazarus, 57, chairman and chief executive officer of Ogilvy & Mather Worldwide, one of the world's leading advertising and marketing communication companies, will join the company's Board of Directors effective Oct. 26. With her election, Ms. Lazarus will...
- Research articles 2004-10-06
- Merck & Co.'s Lewent, Georgia Tech's White, nominated to Motorola Board of Directors
- SCHAUMBURG, Ill.--BUSINESS WIRE--March 21, 1995--Judy Lewent, Senior Vice President and Chief Financial Officer, Merck & Co., Inc. and John White, Dean of Engineering, Georgia Institute of Technology, have been nominated to stand for election to the Motorola Board of Directors. Stockholders will vote on the nominations at Motorola's annual...
- Research articles 1995-03-21
- Molecular Biosystems appoints Jerry T. Jackson to board of directors
- SAN DIEGO--BUSINESS WIRE--Dec. 18, 1996--Molecular Biosystems Inc. (NYSE:MB) MBI Wednesday announced that Jerry T. Jackson, former executive vice president of Merck & Co. Inc., has been appointed to the company's board of directors. Jackson brings 30 years of worldwide marketing, sales and product launch experience to MBI....
- Research articles 1996-12-18
- Champion International Corporation Elects Lawrence A. Bossidy To Board Of Directors
- STAMFORD, CT--BUSINESS WIRE--October 19, 1995--Champion International Corporation today announced that Lawrence A. Bossidy has been elected to the Board of Directors.Mr. Bossidy is Chairman and Chief Executive Officer of AlliedSignal Inc., which he joined in 1991. From 1957 to 1991, he served in various executive and financial positions, including...
- Research articles 1995-10-19
- Bennett M. Shapiro. (Jobs and People).(been appointed to the board of directors of Elixir Pharmaceuticals Inc.)(Brief Article)
- Bennett M. Shapiro has been appointed to the board of directors of Elixir Pharmaceuticals Inc. Dr. Shapiro is currently executive vice president of worldwide licensing and external research at Merck & Co. Inc. He has extensive pharmaceutical business and research experience.
- Research articles 2003-04-21
- Merck board declares dividend and approves $3 billion treasury stock purchase program
- WHITEHOUSE STATION, N.J.--BUSINESS WIRE--Nov. 28, 1995--The Board of Directors of Merck & Co., Inc., in two separate actions today, declared a quarterly dividend of 34 cents a share and approved a new $3 billion treasury stock purchase program.
- Research articles 1995-11-28
- Merck Board Declares Dividend And Approves $2 Billion Treasury Stock Purchase Program
- WHITEHOUSE STATION, N.J.--BUSINESS WIRE--November 22, 1994-- The Board of Directors of Merck & Co., Inc., in two separate actions today, declared a quarterly dividend of 30 cents a share and approved a new $2 billion treasury stock purchase program.
- Research articles 1994-11-22
- K2 Inc. Appoints Richard J. Heckmann as Executive Chairman and J. Wayne Merck as CEO
- CARLSBAD, Calif. -- K2 Inc. (NYSE: KTO) announced today that J. Wayne Merck was appointed as the Company's President and Chief Executive Officer, and to K2's Board of Directors. Mr. Merck, a 15-year veteran of K2 Inc. and its predecessor companies, has served as President and Chief Operating Officer since...
- Research articles 2007-02-16
- Merck & Co. Inc.
- MERCK & Co. Inc.'s board of directors has approved a $10 billion treasury stock repurchase. Merck is currently making purchases under a July 1998, $5 billion authorization, ... MERCK & Co. Inc.'s board of directors has approved a $10 billion treasury stock repurchase. Merck...
- Research articles 2000-02-28
- Merck Board Appoints Special Committee to Review VIOXX Withdrawal
- WHITEHOUSE STATION, N.J. -- The Board of Directors of Merck & Co., Inc. announced today that it has appointed a Special Board Committee to review the company's actions prior to Merck's voluntary withdrawal of VIOXX, to act for the Board in responding to shareholder litigation matters related to the withdrawal...
- Research articles 2004-12-07
- Merck Announces 2 for 1 Stock Split and Quarterly Dividend
- WHITEHOUSE STATION, N.J.--BUSINESS WIRE--Nov. 24, 1998--The Board of Directors of Merck & Co., Inc., meeting today, voted to split the common stock of the Company two for one. The additional shares will be distributed on or about February 16, 1999, to shareholders of record at the close of business on...
- Research articles 1998-11-24
- Valeant Executive Pay Doubles to $19.7 Million Despite Quadrupling of Company's Losses
- Valeant Pharmaceuticals saw its revenues decline, its net loss quadruple, and its cash sink by $109 million in 2008. But the compensation of its top executives doubled, to $19.7 million in 2008 from $8.6 million in 2007. Half of that, $9.7 million, went to CEO J. Michael...
- Blog posts 2009-03-27
- Merck Announces Dividend Increase and $5 Billion Share Repurchase Program
- WHITEHOUSE STATION, N.J.--BUSINESS WIRE--July 28, 1998--The Board of Directors of Merck & Co., Inc., in two separate actions, declared a quarterly dividend of 54 cents a share and approved a new $5 billion treasury stock purchase program.
- Research articles 1998-07-28
- Merck announces dividend increase and $5 billion share repurchase program
- WHITEHOUSE STATION, N.J.--BUSINESS WIRE--February 25, 1997-- The Board of Directors of Merck & Co., Inc., in two separate actions, declared a quarterly dividend of 42 cents a share and approved a new $5 billion treasury stock purchase program.
- Research articles 1997-02-25
- Genta Appoints Kenneth G. Kasses as President and CEO
- SAN DIEGO--BUSINESS WIRE--Sept. 22, 1997--Genta Incorporated (Nasdaq: GNTA) today announced that its Board of Directors has appointed Kenneth G. Kasses, Ph.D., 52, as President and Chief Executive Officer effective October 1, filling a previous vacancy. He has also been named a director of the Company, bringing total membership of the...
- Research articles 1997-09-22
- Norwood Abbey Appoints Three USA Based Non-Executive Directors
- MELBOURNE, Australia -- Norwood Abbey Ltd. (other-OTC:NABYF) (ASX:NAL):Key Points: -- Three new USA based directors appointed to Norwood Abbey Board of Directors -- Elizabeth Wyatt -- former Vice...
- Research articles 2004-10-05
- Integrated Healthcare Association Names CIGNA, Merck Members
- The Integrated Healthcare Association IHA, a statewide leadership group active in health care policy and managed care issues, announces the appointment of two new members to its board of directors: Timothy C. Duffey, executive director of managed care for Merck & Co., Inc.; and Peter B. Welch, president and...
- Research articles 1970-01-01
- Applera Corporation F1Q08 (Qtr End 9/30/07) Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you sir. [Operator’s instructions.] One moment while we compile a list of questions. Our first question will come from the line of Ross Muken of Deutsche Bank, please proceed. Ross Muken – Deutsche Bank Good morning everyone. Mark P. Stevenson –...
- Earnings calls 2007-10-25
- Wyeth CEO Got 69% Pay Raise; Was "Required" to Use Helicopter; Plus $24 Million Pfizer Sale Bonus
- Wyeth CEO Bernard Poussot received a 69 percent compensation raise in 2008, to $21.3 million, in addition to a $24 million change-in-control bonus for selling his company to Pfizer.* Wyeth also took the explanation of executive perks to new levels, saying that Wyeth "requires" Poussot to travel...
- Blog posts 2009-03-30
- Galt Appoints Former Merck & Co. Senior Vice President Dr. Louis Sherwood to Board of Directors; Sherwood to Help Drive Drug Safety Company's Direction and Growth
- Business/Technology Editors & Health/Medical Writers
- Research articles 2002-06-17
- << Previous
- page 1 of 2
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
